Report Overview
Neurodegenerative diseases are a group of disorders characterized by the progressive degeneration of the structure and function of the nervous system, leading to cognitive and motor impairments. Examples include Alzheimer's disease, Parkinson's disease, and amyotrophic lateral sclerosis (ALS).
The global Neurodegenerative Disease market size was estimated at USD 7003.20 million in 2023 and is projected to reach USD 9217.74 million by 2032, exhibiting a CAGR of 3.10% during the forecast period.
North America Neurodegenerative Disease market size was estimated at USD 1923.10 million in 2023, at a CAGR of 2.66% during the forecast period of 2025 through 2032.
This report provides a deep insight into the global Neurodegenerative Disease market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Neurodegenerative Disease Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Neurodegenerative Disease market in any manner.
Global Neurodegenerative Disease Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
Novartis
Pfizer
Merck Serono
Biogen Idec
TEVA
UCB
Boehringer Ingelheim
Sanofi
GlaxoSmithKline
Livzon Pharmaceutical
Haisco Pharmaceutical
Jingxin Pharmaceutical
Dongcheng Biochemicals
Hisun Pharmaceutical
Luye Pharma
Ark Pharmaceutical
Kanghong Pharmaceutical
Huahai Pharmaceutical
BORA PHARMACEUTICALS
Market Segmentation (by Type)
NMDA
SSRIs
Dopamine Inhibitors
Market Segmentation (by Application)
Parkinson
TABLE OF CONTENTS
Table of Contents
1 Research Methodology and Statistical Scope
1.1 Market Definition and Statistical Scope of Neurodegenerative Disease
1.2 Key Market Segments
1.2.1 Neurodegenerative Disease Segment by Type
1.2.2 Neurodegenerative Disease Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 Neurodegenerative Disease Market Overview
2.1 Global Market Overview
2.1.1 Global Neurodegenerative Disease Market Size (M USD) Estimates and Forecasts (2019-2032)
2.1.2 Global Neurodegenerative Disease Sales Estimates and Forecasts (2019-2032)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 Neurodegenerative Disease Market Competitive Landscape
3.1 Global Neurodegenerative Disease Sales by Manufacturers (2019-2025)
3.2 Global Neurodegenerative Disease Revenue Market Share by Manufacturers (2019-2025)
3.3 Neurodegenerative Disease Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Neurodegenerative Disease Average Price by Manufacturers (2019-2025)
3.5 Manufacturers Neurodegenerative Disease Sales Sites, Area Served, Product Type
3.6 Neurodegenerative Disease Market Competitive Situation and Trends
3.6.1 Neurodegenerative Disease Market Concentration Rate
3.6.2 Global 5 and 10 Largest Neurodegenerative Disease Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 Neurodegenerative Disease Industry Chain Analysis
4.1 Neurodegenerative Disease Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 The Development and Dynamics of Neurodegenerative Disease Market
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 Neurodegenerative Disease Market Segmentation by Type
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Neurodegenerative Disease Sales Market Share by Type (2019-2025)
6.3 Global Neurodegenerative Disease Market Size Market Share by Type (2019-2025)
6.4 Global Neurodegenerative Disease Price by Type (2019-2025)
7 Neurodegenerative Disease Market Segmentation by Application
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Neurodegenerative Disease Market Sales by Application (2019-2025)
7.3 Global Neurodegenerative Disease Market Size (M USD) by Application (2019-2025)
7.4 Global Neurodegenerative Disease Sales Growth Rate by Application (2019-2025)
8 Neurodegenerative Disease Market Consumption by Region
8.1 Global Neurodegenerative Disease Sales by Region
8.1.1 Global Neurodegenerative Disease Sales by Region
8.1.2 Global Neurodegenerative Disease Sales Market Share by Region
8.2 North America
8.2.1 North America Neurodegenerative Disease Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Neurodegenerative Disease Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Neurodegenerative Disease Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Neurodegenerative Disease Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Neurodegenerative Disease Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 Neurodegenerative Disease Market Production by Region
9.1 Global Production of Neurodegenerative Disease by Region (2019-2025)
9.2 Global Neurodegenerative Disease Revenue Market Share by Region (2019-2025)
9.3 Global Neurodegenerative Disease Production, Revenue, Price and Gross Margin (2019-2025)
9.4 North America Neurodegenerative Disease Production
9.4.1 North America Neurodegenerative Disease Production Growth Rate (2019-2025)
9.4.2 North America Neurodegenerative Disease Production, Revenue, Price and Gross Margin (2019-2025)
9.5 Europe Neurodegenerative Disease Production
9.5.1 Europe Neurodegenerative Disease Production Growth Rate (2019-2025)
9.5.2 Europe Neurodegenerative Disease Production, Revenue, Price and Gross Margin (2019-2025)
9.6 Japan Neurodegenerative Disease Production (2019-2025)
9.6.1 Japan Neurodegenerative Disease Production Growth Rate (2019-2025)
9.6.2 Japan Neurodegenerative Disease Production, Revenue, Price and Gross Margin (2019-2025)
9.7 China Neurodegenerative Disease Production (2019-2025)
9.7.1 China Neurodegenerative Disease Production Growth Rate (2019-2025)
9.7.2 China Neurodegenerative Disease Production, Revenue, Price and Gross Margin (2019-2025)
10 Key Companies Profile
10.1 Novartis
10.1.1 Novartis Neurodegenerative Disease Basic Information
10.1.2 Novartis Neurodegenerative Disease Product Overview
10.1.3 Novartis Neurodegenerative Disease Product Market Performance
10.1.4 Novartis Business Overview
10.1.5 Novartis Neurodegenerative Disease SWOT Analysis
10.1.6 Novartis Recent Developments
10.2 Pfizer
10.2.1 Pfizer Neurodegenerative Disease Basic Information
10.2.2 Pfizer Neurodegenerative Disease Product Overview
10.2.3 Pfizer Neurodegenerative Disease Product Market Performance
10.2.4 Pfizer Business Overview
10.2.5 Pfizer Neurodegenerative Disease SWOT Analysis
10.2.6 Pfizer Recent Developments
10.3 Merck Serono
10.3.1 Merck Serono Neurodegenerative Disease Basic Information
10.3.2 Merck Serono Neurodegenerative Disease Product Overview
10.3.3 Merck Serono Neurodegenerative Disease Product Market Performance
10.3.4 Merck Serono Neurodegenerative Disease SWOT Analysis
10.3.5 Merck Serono Business Overview
10.3.6 Merck Serono Recent Developments
10.4 Biogen Idec
10.4.1 Biogen Idec Neurodegenerative Disease Basic Information
10.4.2 Biogen Idec Neurodegenerative Disease Product Overview
10.4.3 Biogen Idec Neurodegenerative Disease Product Market Performance
10.4.4 Biogen Idec Business Overview
10.4.5 Biogen Idec Recent Developments
10.5 TEVA
10.5.1 TEVA Neurodegenerative Disease Basic Information
10.5.2 TEVA Neurodegenerative Disease Product Overview
10.5.3 TEVA Neurodegenerative Disease Product Market Performance
10.5.4 TEVA Business Overview
10.5.5 TEVA Recent Developments
10.6 UCB
10.6.1 UCB Neurodegenerative Disease Basic Information
10.6.2 UCB Neurodegenerative Disease Product Overview
10.6.3 UCB Neurodegenerative Disease Product Market Performance
10.6.4 UCB Business Overview
10.6.5 UCB Recent Developments
10.7 Boehringer Ingelheim
10.7.1 Boehringer Ingelheim Neurodegenerative Disease Basic Information
10.7.2 Boehringer Ingelheim Neurodegenerative Disease Product Overview
10.7.3 Boehringer Ingelheim Neurodegenerative Disease Product Market Performance
10.7.4 Boehringer Ingelheim Business Overview
10.7.5 Boehringer Ingelheim Recent Developments
10.8 Sanofi
10.8.1 Sanofi Neurodegenerative Disease Basic Information
10.8.2 Sanofi Neurodegenerative Disease Product Overview
10.8.3 Sanofi Neurodegenerative Disease Product Market Performance
10.8.4 Sanofi Business Overview
10.8.5 Sanofi Recent Developments
10.9 GlaxoSmithKline
10.9.1 GlaxoSmithKline Neurodegenerative Disease Basic Information
10.9.2 GlaxoSmithKline Neurodegenerative Disease Product Overview
10.9.3 GlaxoSmithKline Neurodegenerative Disease Product Market Performance
10.9.4 GlaxoSmithKline Business Overview
10.9.5 GlaxoSmithKline Recent Developments
10.10 Livzon Pharmaceutical
10.10.1 Livzon Pharmaceutical Neurodegenerative Disease Basic Information
10.10.2 Livzon Pharmaceutical Neurodegenerative Disease Product Overview
10.10.3 Livzon Pharmaceutical Neurodegenerative Disease Product Market Performance
10.10.4 Livzon Pharmaceutical Business Overview
10.10.5 Livzon Pharmaceutical Recent Developments
10.11 Haisco Pharmaceutical
10.11.1 Haisco Pharmaceutical Neurodegenerative Disease Basic Information
10.11.2 Haisco Pharmaceutical Neurodegenerative Disease Product Overview
10.11.3 Haisco Pharmaceutical Neurodegenerative Disease Product Market Performance
10.11.4 Haisco Pharmaceutical Business Overview
10.11.5 Haisco Pharmaceutical Recent Developments
10.12 Jingxin Pharmaceutical
10.12.1 Jingxin Pharmaceutical Neurodegenerative Disease Basic Information
10.12.2 Jingxin Pharmaceutical Neurodegenerative Disease Product Overview
10.12.3 Jingxin Pharmaceutical Neurodegenerative Disease Product Market Performance
10.12.4 Jingxin Pharmaceutical Business Overview
10.12.5 Jingxin Pharmaceutical Recent Developments
10.13 Dongcheng Biochemicals
10.13.1 Dongcheng Biochemicals Neurodegenerative Disease Basic Information
10.13.2 Dongcheng Biochemicals Neurodegenerative Disease Product Overview
10.13.3 Dongcheng Biochemicals Neurodegenerative Disease Product Market Performance
10.13.4 Dongcheng Biochemicals Business Overview
10.13.5 Dongcheng Biochemicals Recent Developments
10.14 Hisun Pharmaceutical
10.14.1 Hisun Pharmaceutical Neurodegenerative Disease Basic Information
10.14.2 Hisun Pharmaceutical Neurodegenerative Disease Product Overview
10.14.3 Hisun Pharmaceutical Neurodegenerative Disease Product Market Performance
10.14.4 Hisun Pharmaceutical Business Overview
10.14.5 Hisun Pharmaceutical Recent Developments
10.15 Luye Pharma
10.15.1 Luye Pharma Neurodegenerative Disease Basic Information
10.15.2 Luye Pharma Neurodegenerative Disease Product Overview
10.15.3 Luye Pharma Neurodegenerative Disease Product Market Performance
10.15.4 Luye Pharma Business Overview
10.15.5 Luye Pharma Recent Developments
10.16 Ark Pharmaceutical
10.16.1 Ark Pharmaceutical Neurodegenerative Disease Basic Information
10.16.2 Ark Pharmaceutical Neurodegenerative Disease Product Overview
10.16.3 Ark Pharmaceutical Neurodegenerative Disease Product Market Performance
10.16.4 Ark Pharmaceutical Business Overview
10.16.5 Ark Pharmaceutical Recent Developments
10.17 Kanghong Pharmaceutical
10.17.1 Kanghong Pharmaceutical Neurodegenerative Disease Basic Information
10.17.2 Kanghong Pharmaceutical Neurodegenerative Disease Product Overview
10.17.3 Kanghong Pharmaceutical Neurodegenerative Disease Product Market Performance
10.17.4 Kanghong Pharmaceutical Business Overview
10.17.5 Kanghong Pharmaceutical Recent Developments
10.18 Huahai Pharmaceutical
10.18.1 Huahai Pharmaceutical Neurodegenerative Disease Basic Information
10.18.2 Huahai Pharmaceutical Neurodegenerative Disease Product Overview
10.18.3 Huahai Pharmaceutical Neurodegenerative Disease Product Market Performance
10.18.4 Huahai Pharmaceutical Business Overview
10.18.5 Huahai Pharmaceutical Recent Developments
10.19 BORA PHARMACEUTICALS
10.19.1 BORA PHARMACEUTICALS Neurodegenerative Disease Basic Information
10.19.2 BORA PHARMACEUTICALS Neurodegenerative Disease Product Overview
10.19.3 BORA PHARMACEUTICALS Neurodegenerative Disease Product Market Performance
10.19.4 BORA PHARMACEUTICALS Business Overview
10.19.5 BORA PHARMACEUTICALS Recent Developments
11 Neurodegenerative Disease Market Forecast by Region
11.1 Global Neurodegenerative Disease Market Size Forecast
11.2 Global Neurodegenerative Disease Market Forecast by Region
11.2.1 North America Market Size Forecast by Country
11.2.2 Europe Neurodegenerative Disease Market Size Forecast by Country
11.2.3 Asia Pacific Neurodegenerative Disease Market Size Forecast by Region
11.2.4 South America Neurodegenerative Disease Market Size Forecast by Country
11.2.5 Middle East and Africa Forecasted Consumption of Neurodegenerative Disease by Country
12 Forecast Market by Type and by Application (2025-2032)
12.1 Global Neurodegenerative Disease Market Forecast by Type (2025-2032)
12.1.1 Global Forecasted Sales of Neurodegenerative Disease by Type (2025-2032)
12.1.2 Global Neurodegenerative Disease Market Size Forecast by Type (2025-2032)
12.1.3 Global Forecasted Price of Neurodegenerative Disease by Type (2025-2032)
12.2 Global Neurodegenerative Disease Market Forecast by Application (2025-2032)
12.2.1 Global Neurodegenerative Disease Sales (K MT) Forecast by Application
12.2.2 Global Neurodegenerative Disease Market Size (M USD) Forecast by Application (2025-2032)
13 Conclusion and Key Findings
LIST OF TABLES & FIGURES
List of Tables
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Neurodegenerative Disease Market Size Comparison by Region (M USD)
Table 5. Global Neurodegenerative Disease Sales (K MT) by Manufacturers (2019-2025)
Table 6. Global Neurodegenerative Disease Sales Market Share by Manufacturers (2019-2025)
Table 7. Global Neurodegenerative Disease Revenue (M USD) by Manufacturers (2019-2025)
Table 8. Global Neurodegenerative Disease Revenue Share by Manufacturers (2019-2025)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Neurodegenerative Disease as of 2022)
Table 10. Global Market Neurodegenerative Disease Average Price (USD/MT) of Key Manufacturers (2019-2025)
Table 11. Manufacturers Neurodegenerative Disease Sales Sites and Area Served
Table 12. Manufacturers Neurodegenerative Disease Product Type
Table 13. Global Neurodegenerative Disease Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Industry Chain Map of Neurodegenerative Disease
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Neurodegenerative Disease Market Challenges
Table 22. Global Neurodegenerative Disease Sales by Type (K MT)
Table 23. Global Neurodegenerative Disease Market Size by Type (M USD)
Table 24. Global Neurodegenerative Disease Sales (K MT) by Type (2019-2025)
Table 25. Global Neurodegenerative Disease Sales Market Share by Type (2019-2025)
Table 26. Global Neurodegenerative Disease Market Size (M USD) by Type (2019-2025)
Table 27. Global Neurodegenerative Disease Market Size Share by Type (2019-2025)
Table 28. Global Neurodegenerative Disease Price (USD/MT) by Type (2019-2025)
Table 29. Global Neurodegenerative Disease Sales (K MT) by Application
Table 30. Global Neurodegenerative Disease Market Size by Application
Table 31. Global Neurodegenerative Disease Sales by Application (2019-2025) & (K MT)
Table 32. Global Neurodegenerative Disease Sales Market Share by Application (2019-2025)
Table 33. Global Neurodegenerative Disease Sales by Application (2019-2025) & (M USD)
Table 34. Global Neurodegenerative Disease Market Share by Application (2019-2025)
Table 35. Global Neurodegenerative Disease Sales Growth Rate by Application (2019-2025)
Table 36. Global Neurodegenerative Disease Sales by Region (2019-2025) & (K MT)
Table 37. Global Neurodegenerative Disease Sales Market Share by Region (2019-2025)
Table 38. North America Neurodegenerative Disease Sales by Country (2019-2025) & (K MT)
Table 39. Europe Neurodegenerative Disease Sales by Country (2019-2025) & (K MT)
Table 40. Asia Pacific Neurodegenerative Disease Sales by Region (2019-2025) & (K MT)
Table 41. South America Neurodegenerative Disease Sales by Country (2019-2025) & (K MT)
Table 42. Middle East and Africa Neurodegenerative Disease Sales by Region (2019-2025) & (K MT)
Table 43. Global Neurodegenerative Disease Production (K MT) by Region (2019-2025)
Table 44. Global Neurodegenerative Disease Revenue (US$ Million) by Region (2019-2025)
Table 45. Global Neurodegenerative Disease Revenue Market Share by Region (2019-2025)
Table 46. Global Neurodegenerative Disease Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2025)
Table 47. North America Neurodegenerative Disease Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2025)
Table 48. Europe Neurodegenerative Disease Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2025)
Table 49. Japan Neurodegenerative Disease Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2025)
Table 50. China Neurodegenerative Disease Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2025)
Table 51. Novartis Neurodegenerative Disease Basic Information
Table 52. Novartis Neurodegenerative Disease Product Overview
Table 53. Novartis Neurodegenerative Disease Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2025)
Table 54. Novartis Business Overview
Table 55. Novartis Neurodegenerative Disease SWOT Analysis
Table 56. Novartis Recent Developments
Table 57. Pfizer Neurodegenerative Disease Basic Information
Table 58. Pfizer Neurodegenerative Disease Product Overview
Table 59. Pfizer Neurodegenerative Disease Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2025)
Table 60. Pfizer Business Overview
Table 61. Pfizer Neurodegenerative Disease SWOT Analysis
Table 62. Pfizer Recent Developments
Table 63. Merck Serono Neurodegenerative Disease Basic Information
Table 64. Merck Serono Neurodegenerative Disease Product Overview
Table 65. Merck Serono Neurodegenerative Disease Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2025)
Table 66. Merck Serono Neurodegenerative Disease SWOT Analysis
Table 67. Merck Serono Business Overview
Table 68. Merck Serono Recent Developments
Table 69. Biogen Idec Neurodegenerative Disease Basic Information
Table 70. Biogen Idec Neurodegenerative Disease Product Overview
Table 71. Biogen Idec Neurodegenerative Disease Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2025)
Table 72. Biogen Idec Business Overview
Table 73. Biogen Idec Recent Developments
Table 74. TEVA Neurodegenerative Disease Basic Information
Table 75. TEVA Neurodegenerative Disease Product Overview
Table 76. TEVA Neurodegenerative Disease Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2025)
Table 77. TEVA Business Overview
Table 78. TEVA Recent Developments
Table 79. UCB Neurodegenerative Disease Basic Information
Table 80. UCB Neurodegenerative Disease Product Overview
Table 81. UCB Neurodegenerative Disease Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2025)
Table 82. UCB Business Overview
Table 83. UCB Recent Developments
Table 84. Boehringer Ingelheim Neurodegenerative Disease Basic Information
Table 85. Boehringer Ingelheim Neurodegenerative Disease Product Overview
Table 86. Boehringer Ingelheim Neurodegenerative Disease Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2025)
Table 87. Boehringer Ingelheim Business Overview
Table 88. Boehringer Ingelheim Recent Developments
Table 89. Sanofi Neurodegenerative Disease Basic Information
Table 90. Sanofi Neurodegenerative Disease Product Overview
Table 91. Sanofi Neurodegenerative Disease Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2025)
Table 92. Sanofi Business Overview
Table 93. Sanofi Recent Developments
Table 94. GlaxoSmithKline Neurodegenerative Disease Basic Information
Table 95. GlaxoSmithKline Neurodegenerative Disease Product Overview
Table 96. GlaxoSmithKline Neurodegenerative Disease Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2025)
Table 97. GlaxoSmithKline Business Overview
Table 98. GlaxoSmithKline Recent Developments
Table 99. Livzon Pharmaceutical Neurodegenerative Disease Basic Information
Table 100. Livzon Pharmaceutical Neurodegenerative Disease Product Overview
Table 101. Livzon Pharmaceutical Neurodegenerative Disease Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2025)
Table 102. Livzon Pharmaceutical Business Overview
Table 103. Livzon Pharmaceutical Recent Developments
Table 104. Haisco Pharmaceutical Neurodegenerative Disease Basic Information
Table 105. Haisco Pharmaceutical Neurodegenerative Disease Product Overview
Table 106. Haisco Pharmaceutical Neurodegenerative Disease Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2025)
Table 107. Haisco Pharmaceutical Business Overview
Table 108. Haisco Pharmaceutical Recent Developments
Table 109. Jingxin Pharmaceutical Neurodegenerative Disease Basic Information
Table 110. Jingxin Pharmaceutical Neurodegenerative Disease Product Overview
Table 111. Jingxin Pharmaceutical Neurodegenerative Disease Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2025)
Table 112. Jingxin Pharmaceutical Business Overview
Table 113. Jingxin Pharmaceutical Recent Developments
Table 114. Dongcheng Biochemicals Neurodegenerative Disease Basic Information
Table 115. Dongcheng Biochemicals Neurodegenerative Disease Product Overview
Table 116. Dongcheng Biochemicals Neurodegenerative Disease Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2025)
Table 117. Dongcheng Biochemicals Business Overview
Table 118. Dongcheng Biochemicals Recent Developments
Table 119. Hisun Pharmaceutical Neurodegenerative Disease Basic Information
Table 120. Hisun Pharmaceutical Neurodegenerative Disease Product Overview
Table 121. Hisun Pharmaceutical Neurodegenerative Disease Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2025)
Table 122. Hisun Pharmaceutical Business Overview
Table 123. Hisun Pharmaceutical Recent Developments
Table 124. Luye Pharma Neurodegenerative Disease Basic Information
Table 125. Luye Pharma Neurodegenerative Disease Product Overview
Table 126. Luye Pharma Neurodegenerative Disease Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2025)
Table 127. Luye Pharma Business Overview
Table 128. Luye Pharma Recent Developments
Table 129. Ark Pharmaceutical Neurodegenerative Disease Basic Information
Table 130. Ark Pharmaceutical Neurodegenerative Disease Product Overview
Table 131. Ark Pharmaceutical Neurodegenerative Disease Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2025)
Table 132. Ark Pharmaceutical Business Overview
Table 133. Ark Pharmaceutical Recent Developments
Table 134. Kanghong Pharmaceutical Neurodegenerative Disease Basic Information
Table 135. Kanghong Pharmaceutical Neurodegenerative Disease Product Overview
Table 136. Kanghong Pharmaceutical Neurodegenerative Disease Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2025)
Table 137. Kanghong Pharmaceutical Business Overview
Table 138. Kanghong Pharmaceutical Recent Developments
Table 139. Huahai Pharmaceutical Neurodegenerative Disease Basic Information
Table 140. Huahai Pharmaceutical Neurodegenerative Disease Product Overview
Table 141. Huahai Pharmaceutical Neurodegenerative Disease Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2025)
Table 142. Huahai Pharmaceutical Business Overview
Table 143. Huahai Pharmaceutical Recent Developments
Table 144. BORA PHARMACEUTICALS Neurodegenerative Disease Basic Information
Table 145. BORA PHARMACEUTICALS Neurodegenerative Disease Product Overview
Table 146. BORA PHARMACEUTICALS Neurodegenerative Disease Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2025)
Table 147. BORA PHARMACEUTICALS Business Overview
Table 148. BORA PHARMACEUTICALS Recent Developments
Table 149. Global Neurodegenerative Disease Sales Forecast by Region (2025-2032) & (K MT)
Table 150. Global Neurodegenerative Disease Market Size Forecast by Region (2025-2032) & (M USD)
Table 151. North America Neurodegenerative Disease Sales Forecast by Country (2025-2032) & (K MT)
Table 152. North America Neurodegenerative Disease Market Size Forecast by Country (2025-2032) & (M USD)
Table 153. Europe Neurodegenerative Disease Sales Forecast by Country (2025-2032) & (K MT)
Table 154. Europe Neurodegenerative Disease Market Size Forecast by Country (2025-2032) & (M USD)
Table 155. Asia Pacific Neurodegenerative Disease Sales Forecast by Region (2025-2032) & (K MT)
Table 156. Asia Pacific Neurodegenerative Disease Market Size Forecast by Region (2025-2032) & (M USD)
Table 157. South America Neurodegenerative Disease Sales Forecast by Country (2025-2032) & (K MT)
Table 158. South America Neurodegenerative Disease Market Size Forecast by Country (2025-2032) & (M USD)
Table 159. Middle East and Africa Neurodegenerative Disease Consumption Forecast by Country (2025-2032) & (Units)
Table 160. Middle East and Africa Neurodegenerative Disease Market Size Forecast by Country (2025-2032) & (M USD)
Table 161. Global Neurodegenerative Disease Sales Forecast by Type (2025-2032) & (K MT)
Table 162. Global Neurodegenerative Disease Market Size Forecast by Type (2025-2032) & (M USD)
Table 163. Global Neurodegenerative Disease Price Forecast by Type (2025-2032) & (USD/MT)
Table 164. Global Neurodegenerative Disease Sales (K MT) Forecast by Application (2025-2032)
Table 165. Global Neurodegenerative Disease Market Size Forecast by Application (2025-2032) & (M USD)
List of Figures
Figure 1. Product Picture of Neurodegenerative Disease
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Neurodegenerative Disease Market Size (M USD), 2019-2032
Figure 5. Global Neurodegenerative Disease Market Size (M USD) (2019-2032)
Figure 6. Global Neurodegenerative Disease Sales (K MT) & (2019-2032)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Neurodegenerative Disease Market Size by Country (M USD)
Figure 11. Neurodegenerative Disease Sales Share by Manufacturers in 2023
Figure 12. Global Neurodegenerative Disease Revenue Share by Manufacturers in 2023
Figure 13. Neurodegenerative Disease Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2023
Figure 14. Global Market Neurodegenerative Disease Average Price (USD/MT) of Key Manufacturers in 2023
Figure 15. The Global 5 and 10 Largest Players: Market Share by Neurodegenerative Disease Revenue in 2023
Figure 16. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 17. Global Neurodegenerative Disease Market Share by Type
Figure 18. Sales Market Share of Neurodegenerative Disease by Type (2019-2025)
Figure 19. Sales Market Share of Neurodegenerative Disease by Type in 2023
Figure 20. Market Size Share of Neurodegenerative Disease by Type (2019-2025)
Figure 21. Market Size Market Share of Neurodegenerative Disease by Type in 2023
Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 23. Global Neurodegenerative Disease Market Share by Application
Figure 24. Global Neurodegenerative Disease Sales Market Share by Application (2019-2025)
Figure 25. Global Neurodegenerative Disease Sales Market Share by Application in 2023
Figure 26. Global Neurodegenerative Disease Market Share by Application (2019-2025)
Figure 27. Global Neurodegenerative Disease Market Share by Application in 2023
Figure 28. Global Neurodegenerative Disease Sales Growth Rate by Application (2019-2025)
Figure 29. Global Neurodegenerative Disease Sales Market Share by Region (2019-2025)
Figure 30. North America Neurodegenerative Disease Sales and Growth Rate (2019-2025) & (K MT)
Figure 31. North America Neurodegenerative Disease Sales Market Share by Country in 2023
Figure 32. U.S. Neurodegenerative Disease Sales and Growth Rate (2019-2025) & (K MT)
Figure 33. Canada Neurodegenerative Disease Sales (K MT) and Growth Rate (2019-2025)
Figure 34. Mexico Neurodegenerative Disease Sales (Units) and Growth Rate (2019-2025)
Figure 35. Europe Neurodegenerative Disease Sales and Growth Rate (2019-2025) & (K MT)
Figure 36. Europe Neurodegenerative Disease Sales Market Share by Country in 2023
Figure 37. Germany Neurodegenerative Disease Sales and Growth Rate (2019-2025) & (K MT)
Figure 38. France Neurodegenerative Disease Sales and Growth Rate (2019-2025) & (K MT)
Figure 39. U.K. Neurodegenerative Disease Sales and Growth Rate (2019-2025) & (K MT)
Figure 40. Italy Neurodegenerative Disease Sales and Growth Rate (2019-2025) & (K MT)
Figure 41. Russia Neurodegenerative Disease Sales and Growth Rate (2019-2025) & (K MT)
Figure 42. Asia Pacific Neurodegenerative Disease Sales and Growth Rate (K MT)
Figure 43. Asia Pacific Neurodegenerative Disease Sales Market Share by Region in 2023
Figure 44. China Neurodegenerative Disease Sales and Growth Rate (2019-2025) & (K MT)
Figure 45. Japan Neurodegenerative Disease Sales and Growth Rate (2019-2025) & (K MT)
Figure 46. South Korea Neurodegenerative Disease Sales and Growth Rate (2019-2025) & (K MT)
Figure 47. India Neurodegenerative Disease Sales and Growth Rate (2019-2025) & (K MT)
Figure 48. Southeast Asia Neurodegenerative Disease Sales and Growth Rate (2019-2025) & (K MT)
Figure 49. South America Neurodegenerative Disease Sales and Growth Rate (K MT)
Figure 50. South America Neurodegenerative Disease Sales Market Share by Country in 2023
Figure 51. Brazil Neurodegenerative Disease Sales and Growth Rate (2019-2025) & (K MT)
Figure 52. Argentina Neurodegenerative Disease Sales and Growth Rate (2019-2025) & (K MT)
Figure 53. Columbia Neurodegenerative Disease Sales and Growth Rate (2019-2025) & (K MT)
Figure 54. Middle East and Africa Neurodegenerative Disease Sales and Growth Rate (K MT)
Figure 55. Middle East and Africa Neurodegenerative Disease Sales Market Share by Region in 2023
Figure 56. Saudi Arabia Neurodegenerative Disease Sales and Growth Rate (2019-2025) & (K MT)
Figure 57. UAE Neurodegenerative Disease Sales and Growth Rate (2019-2025) & (K MT)
Figure 58. Egypt Neurodegenerative Disease Sales and Growth Rate (2019-2025) & (K MT)
Figure 59. Nigeria Neurodegenerative Disease Sales and Growth Rate (2019-2025) & (K MT)
Figure 60. South Africa Neurodegenerative Disease Sales and Growth Rate (2019-2025) & (K MT)
Figure 61. Global Neurodegenerative Disease Production Market Share by Region (2019-2025)
Figure 62. North America Neurodegenerative Disease Production (K MT) Growth Rate (2019-2025)
Figure 63. Europe Neurodegenerative Disease Production (K MT) Growth Rate (2019-2025)
Figure 64. Japan Neurodegenerative Disease Production (K MT) Growth Rate (2019-2025)
Figure 65. China Neurodegenerative Disease Production (K MT) Growth Rate (2019-2025)
Figure 66. Global Neurodegenerative Disease Sales Forecast by Volume (2019-2032) & (K MT)
Figure 67. Global Neurodegenerative Disease Market Size Forecast by Value (2019-2032) & (M USD)
Figure 68. Global Neurodegenerative Disease Sales Market Share Forecast by Type (2025-2032)
Figure 69. Global Neurodegenerative Disease Market Share Forecast by Type (2025-2032)
Figure 70. Global Neurodegenerative Disease Sales Forecast by Application (2025-2032)
Figure 71. Global Neurodegenerative Disease Market Share Forecast by Application (2025-2032)
